symbol,price,beta,volAvg,mktCap,lastDiv,range,changes,companyName,currency,cik,isin,cusip,exchange,exchangeShortName,industry,website,description,ceo,sector,country,fullTimeEmployees,phone,address,city,state,zip,dcfDiff,dcf,image,ipoDate,defaultImage,isEtf,isActivelyTrading,isAdr,isFund
ANEB,2.44,-1.416082,9135,62545008,0,1.62-4.05,0.73,"Anebulo Pharmaceuticals, Inc.",USD,0001815974,US0345691036,034569103,NASDAQ Capital Market,NASDAQ,Biotechnology,https://www.anebulo.com,"Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing and commercializing treatments for people suffering from acute cannabinoid intoxication and substance addiction. Its lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist to treat cannabinoid intoxication and overdose. The company was incorporated in 2020 and is based in Lakeway, Texas.","Dr. Joseph F. Lawler M.D., Ph.D.",Healthcare,US,2,512 598 0931,1415 Ranch Road 620 South,Lakeway,TX,78734,,0,https://financialmodelingprep.com/image-stock/ANEB.png,2021-05-07,False,False,True,False,False
